Bone marrow stem cells attracted to the site of a cancerous growth frequently take on the outward appearance of the malignant cells around them, University of Florida researchers report in a paper to be published in the August issue of Stem Cells.
When actress Sally Field was diagnosed with osteoporosis in 2005, it was a disappointing development.
The State Natural Resources Board today unanimously extended the reach of emergency rules aimed at preventing the spread of a viral fish disease to include the Lake Winnebago System after preliminary tests showed two dead fish from those waters had viral hemorrhagic septicemia (VHS).
Technology licensed by Follica Inc. from the University of Pennsylvania School of Medicine has been used to generate completely new hair follicles for the first time in normal adult mammals. The paper describing the experiment was published in the May 17th issue of the scientific journal Nature.
Researchers announced that there is strong evidence a chemical referred to as hexavalent chromium, or chromium 6, causes cancer in laboratory animals when it is consumed in drinking water.
Nearly three out of four ulcerative colitis sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of life. Furthermore, they describe UC as disruptive when it comes to their relationship with a spouse (64 percent), their sexual relations (75 percent) and their emotional state (82 percent).
Elsevier announced today the inaugural issue of a new journal, Molecular Oncology ? a journal for discovery-driven translational cancer research, published by Elsevier on behalf of the Federation of European Biochemical Societies (FEBS).
A growing shortage of allergists in the United States may soon impact the quality of patient care for asthma and other allergic diseases, according to a report published by the American College of Allergy, Asthma and Immunology (ACAAI).
Boehringer Ingelheim GmbH announced that it has initiated and begun enrollment of patients in the ArTEN trial, which will compare the efficacy and safety of Viramune? (nevirapine), a non-nucleoside reverse transcriptase inhibitor (NNRTI), dosed once daily (QD) or twice daily (BID), versus atazanavir/ritonavir, a once-daily dosed protease inhibitor (PI).
Commenting on the BMA’s report, Nigel Edwards, director of policy at the NHS Confederation which represents over 90 per cent of NHS organisations, said: